Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.112NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.123NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.143NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.6.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.360NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.49NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.160.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.385NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.384NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.338NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.20.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.445NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.21 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.374NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.63 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.377NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.298NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.76NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.120NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.249NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.505NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-6431.9South Korea
B.1.406NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.115NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used